Rafael Santana-Davila, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Amgen
    Date added: 
    08/21/2023
    Relationship end date: 
    05/01/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Catalyst Pharmaceuticals
    Date added: 
    08/21/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Genentech
    Date added: 
    08/21/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Mirati Therapeutics
    Date added: 
    08/21/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Aztra-Zeneca
    Date added: 
    08/21/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Beyond Spring Pharmaceuticals
    Date added: 
    08/21/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Isa Pharmaceuticals
    Date added: 
    08/21/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Merck
    Date added: 
    08/21/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    Pfizer
    Date added: 
    08/21/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Grant Or Contract
    Ineligible company: 
    ALX Oncology
    Date added: 
    08/21/2023

Pages

Return to Alaska Hematology Oncology Conference